Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

734
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
734

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting clinical exacerbations using respiratory oscillometry during home telemonitoring of patients taking medium-/high-dose asthma treatment.

ERJ open researchĀ·2026
Same author

Association between impulse oscillometry Z-scores and asthma control and exacerbation risk in a tertiary severe asthma clinic.

Frontiers in allergyĀ·2026
Same author

The modified in Manila Medical Research Council dyspnoea scale.

The Lancet. Respiratory medicineĀ·2026
Same author

One-year lung function change and variability post allogeneic hematopoietic stem cell transplantation.

Respiratory medicineĀ·2026
Same author

Supine hyperinflation and expiratory flow limitation are associated with respiratory arousals and nocturnal hypoventilation in COPD.

BMJ open respiratory researchĀ·2025
Same author

Implementation of a preoperative exercise programme in lung cancer resection: protocol for a mixed-methods study.

BMJ openĀ·2025
Same journal

Global, Regional, and National Burden of COPD Attributable to Secondhand Smoke from 1990 to 2021: Findings from the Global Burden of Disease Study 2021.

COPDĀ·2026
Same journal

Upregulation of LncRNA MIR31HG in COPD Correlates with Disease Severity and Facilitates Inflammation via miR-342-3p.

COPDĀ·2026
Same journal

Methodological Considerations in the Development of the AECOPD "Infection Score".

COPDĀ·2026
Same journal

Barriers and Facilitators to Treatment Plan Adoption and Self-Management in People with Chronic Obstructive Pulmonary Disease (COPD): A Systematic Search and Narrative Synthesis.

COPDĀ·2026
Same journal

Airway Mucus Occlusions in Ex-Smokers with and Without COPD.

COPDĀ·2026
Same journal

Symptom Improvement with BDP/FF/G Fixed Triple Inhalation Powder in Moderate to Severe COPD Patients Uncontrolled with Dual Therapies: A Non-Interventional, Open-Label, Single-Arm, Prospective Study (RESPONSE Slovenia).

COPDĀ·2026
See all related articles

Related Experiment Video

Updated: Jan 16, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.3K

Resting Hyperinflation Predicts Incremental Shuttle Walk Distance in Chronic Obstructive Pulmonary Disease.

Meera Srinivasan1,2,3,4, David Touma1,3, Kaj E C Blokland1,3

  • 1Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, NSW, Australia.

COPD
|September 26, 2025
PubMed
Summary
This summary is machine-generated.

In chronic obstructive pulmonary disease (COPD), resting hyperinflation, measured by inspiratory capacity to total lung capacity ratio (IC/TLC), predicts incremental shuttle walk test distance (ISWD). This finding suggests hyperinflation reflects overall COPD impairment rather than limiting exercise performance.

Keywords:
COPDISWTexerciseforced oscillation techniquehyperinflationinspiratory capacityshuttle walk test

More Related Videos

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

791
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K

Related Experiment Videos

Last Updated: Jan 16, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.3K
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

791
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K

Area of Science:

  • Pulmonary Medicine
  • Respiratory Physiology
  • Exercise Science

Background:

  • The incremental shuttle walk test (ISWT) is a key measure in COPD, correlating with mortality, treatment response, and hospital readmissions.
  • Limited data exists on the physiological factors determining ISWT distance (ISWD) in COPD patients.
  • Understanding ISWD determinants is crucial for managing COPD exercise capacity.

Purpose of the Study:

  • To explore the physiological determinants of ISWT distance (ISWD) in patients with COPD.
  • To evaluate the relationship between ISWD, dyspnea (BORG score), and various lung function parameters.
  • To investigate the role of resting hyperinflation in limiting exercise performance in COPD.

Main Methods:

  • Prospective observational study involving 25 COPD patients.
  • Spirometry, lung volumes, diffusion capacity (DLCO), and oscillometry were performed.
  • Patients completed two ISWTs; the best distance was recorded. ISWD and BORG dyspnea scores were analyzed.

Main Results:

  • The inspiratory capacity to total lung capacity ratio (IC/TLC) showed a strong correlation with ISWD (r=0.59, p=0.02), even after adjusting for age and height.
  • Oscillatory reactance (Xrs5) and DLCO also correlated with ISWD.
  • No oscillometric or spirometric factors predicted dyspnea levels; patients reported severe dyspnea at submaximal heart rates.

Conclusions:

  • Resting hyperinflation (IC/TLC) predicts ISWD in COPD, independent of severe dyspnea.
  • This suggests hyperinflation may be an indicator of overall COPD impairment rather than the primary mechanism limiting exercise performance.
  • Further research is needed to fully elucidate the complex interplay of factors affecting exercise capacity in COPD.